Key Players of the Intrauterine Contraceptive Devices Market include Bayer HealthCare AG (A subsidiary of BAYER AG) (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), Medicines360 (Ireland) and other companies.
(PRWEB) April 03, 2015
The global intrauterine contraceptive devices market report defines and segments the concerned market with analysis and forecast of revenue. This market is estimated to reach $4,605.6 million by 2019, at a developing CAGR of 6.8% from 2014 to 2019.
Browse through the TOC of the global intrauterine contraceptive devices market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the market segmentation, and is supported by various tables and figures.
Intrauterine device (IUCD) is a small contraceptive device that is inserted into the uterus to prevent pregnancy. The IUCDs are available in two types, namely copper and hormonal. The hormonal IUCD contains progesterone, which is a synthetic version of the naturally occurring hormone progesterone. Both these types are very effective methods of contraception and can stay in place for an average of at least five years.
Early buyers will receive 10% customization on this report.
The factors driving the intrauterine contraceptive devices market include increasing rate of unplanned pregnancies, effective contraceptive method, and less side effects as compared to other contraceptive methods. In the U.S., around 82% of the adolescent pregnancies are unplanned. The users, especially adolescents, trust the intrauterine devices market, as it is extremely reliable and effective. As a result, long-acting reversible contraception (LARC) methods, such as intrauterine contraceptive devices, are adopted on a large scale.
Speak to Analyst @ http://www.micromarketmonitor.com/contact/9403617870-speak_to_analyst.html
The market in Asia contributed the maximum share of 35.0% to the intrauterine contraceptive devices market globally, as of 2014.
IUCD is safe and more effective than other contraceptives, such as oral contraceptives, as the other contraceptives have several side effects, such as dizziness, headache, lightheadedness, stomach upset, bloating, or nausea.
This market is segmented and forecast on the basis of different type and products. The market based on products includes Mirena, Skyla, Paragard, Essure, and pipeline product Livosert. The market is further segmented and forecast on the basis of major regions, such as the Asia, Europe, North America, and Rest of the World (RoW).
This report also includes the market share, value chain analyses, usage percentage and sales of different products, market metrics such as drivers, restraints and also the upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market.
MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better a understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.
About MicroMarket Monitor:
MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12,000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.
Mr. Chandrasekhar K.
5601 Bridge Street
Fort Worth, TX 76112
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor